• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Diabetic Retinopathy

Diabetic Retinopathy - 37 Studies Found

Completed : Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy
: Diabetic Retinopathy
: 2012-11-07
:
  • Drug: COLIRIOBCN070660 One dro

Completed : Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
: Diabetic Retinopathy
: 2005-08-16
:
  • Drug: Octreotide Acetate in Microspheres 20 mg

Completed : Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone
: Diabetic Retinopathy
: 2009-07-01
:
  • Drug: ranibizumab and vitrectomy

Completed : A Study on Traditional Chinese Medicine (TCM) Comprehensive Protocol of Prevention and Control in Diabetic Retinopathy
: Diabetic Retinopathy
: 2008-12-24
:
  • Drug: Qi ming granula Qi ming

Completed : Severe Proliferative Diabetic Retinopathy
: Diabetic Retinopathy
: 2010-05-03
:
  • Procedure: vitrectomy The surg

Enrolling by invitation : A Multi-center Study to Evaluate Performance of an Automated Device for the Detection of Diabetic Retinopathy
: Diabetic Retinopathy
: 2016-11-10
Terminated : Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
: Diabetic Retinopathy
: 2005-11-02
: Drug: Octreotide acetate in microspheres
Completed : Efficacy of Higher Cutting Rate in Microincision Vitrectomy for Proliferative Diabetic Retinopathy
: Proliferative Diabetic Retinopathy
: 2015-06-02
: Procedure: Vitrectomy for proliferative diabetic retinopathy 25-gauge vitrectomy
Completed : Topical Application of Latanoprost in Diabetic Retinopathy
: Diabetic Retinopathy
: 2010-10-20
: Drug: Latanoprost Topical application Other Name: No
Terminated : Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
: Diabetic Retinopathy
: 2005-11-02
: Drug: Octreotide acetate in microspheres
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.